Propanc Biopharma, Inc.
PPCB· Nasdaq
PPCBPropanc Biopharma, Inc.
Filed Feb 14, 2019 · 10-Q · 45 days after period end · 0001493152-19-002072
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Net Income | -$1.45M | -$2.20M | -$3.76M | -$3.56M |
| EPS Diluted | -$41.33 | -$0.20 | -$1.13 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Feb 14, 2019 · 45 d after period end
